Ohio Public Employees Retirement System (OPERS)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.6M Sell
38,752
-917
-2% -$299K 0.04% 370
2025
Q1
$10.7M Sell
39,669
-4,588
-10% -$1.24M 0.04% 401
2024
Q4
$10.4M Sell
44,257
-4,180
-9% -$984K 0.04% 418
2024
Q3
$13.3M Sell
48,437
-3,275
-6% -$901K 0.06% 327
2024
Q2
$12.6M Buy
51,712
+164
+0.3% +$39.9K 0.05% 316
2024
Q1
$7.7M Sell
51,548
-3,869
-7% -$578K 0.03% 458
2023
Q4
$10.6M Buy
55,417
+747
+1% +$143K 0.04% 365
2023
Q3
$9.68M Sell
54,670
-5,588
-9% -$990K 0.04% 358
2023
Q2
$11.4M Sell
60,258
-5,091
-8% -$967K 0.05% 351
2023
Q1
$13.1M Sell
65,349
-2,750
-4% -$551K 0.05% 328
2022
Q4
$16.2M Buy
68,099
+6,707
+11% +$1.59M 0.07% 272
2022
Q3
$12.3M Buy
61,392
+244
+0.4% +$48.8K 0.06% 326
2022
Q2
$8.92M Sell
61,148
-2,213
-3% -$323K 0.04% 410
2022
Q1
$10.3M Sell
63,361
-1,430
-2% -$234K 0.04% 439
2021
Q4
$11M Sell
64,791
-2,219
-3% -$376K 0.04% 434
2021
Q3
$12.7M Buy
67,010
+49
+0.1% +$9.25K 0.05% 380
2021
Q2
$11.4M Buy
66,961
+4,712
+8% +$799K 0.04% 424
2021
Q1
$8.79M Buy
62,249
+5,516
+10% +$779K 0.03% 464
2020
Q4
$7.37M Buy
56,733
+10,936
+24% +$1.42M 0.03% 478
2020
Q3
$6.67M Buy
45,797
+2,201
+5% +$320K 0.04% 393
2020
Q2
$6.46M Buy
43,596
+684
+2% +$101K 0.04% 437
2020
Q1
$4.67M Buy
42,912
+6,922
+19% +$753K 0.03% 481
2019
Q4
$4.15M Sell
35,990
-1,083
-3% -$125K 0.02% 622
2019
Q3
$2.98M Buy
37,073
+88
+0.2% +$7.08K 0.02% 793
2019
Q2
$2.68M Buy
36,985
+1,680
+5% +$122K 0.01% 842
2019
Q1
$3.3M Buy
35,305
+2,017
+6% +$188K 0.02% 767
2018
Q4
$2.43M Sell
33,288
-2,607
-7% -$190K 0.01% 822
2018
Q3
$3.14M Sell
35,895
-288
-0.8% -$25.2K 0.02% 833
2018
Q2
$3.56M Sell
36,183
-642
-2% -$63.2K 0.02% 791
2018
Q1
$4.39M Sell
36,825
-366
-1% -$43.6K 0.02% 671
2017
Q4
$4.73M Buy
37,191
+4,311
+13% +$548K 0.02% 682
2017
Q3
$3.86M Buy
32,880
+1,026
+3% +$121K 0.02% 733
2017
Q2
$2.54M Sell
31,854
-657
-2% -$52.4K 0.01% 868
2017
Q1
$1.67M Hold
32,511
0.01% 1026
2016
Q4
$1.49M Buy
32,511
+136
+0.4% +$6.25K 0.01% 1075
2016
Q3
$2.19M Buy
32,375
+3,414
+12% +$231K 0.01% 864
2016
Q2
$1.61M Buy
28,961
+1,000
+4% +$55.5K 0.01% 952
2016
Q1
$1.76M Sell
27,961
-14,878
-35% -$934K 0.01% 879
2015
Q4
$4.03M Buy
42,839
+6,145
+17% +$579K 0.02% 551
2015
Q3
$2.95M Sell
36,694
-4,622
-11% -$371K 0.02% 695
2015
Q2
$4.95M Buy
41,316
+1,369
+3% +$164K 0.03% 568
2015
Q1
$4.17M Sell
39,947
-11,965
-23% -$1.25M 0.02% 607
2014
Q4
$5.04M Buy
51,912
+5,153
+11% +$500K 0.03% 545
2014
Q3
$3.65M Buy
46,759
+26,650
+133% +$2.08M 0.02% 655
2014
Q2
$1.27M Buy
+20,109
New +$1.27M 0.01% 1140